Quality of life in women using the vaginal contraceptive ring Ornibel®: Data of an observational study.

Objective The observational study aimed to assess quality of life parameters in women using the vaginal contraceptive ring Ornibel® with a new polymer structure that delivers 0.120 mg etonogestrel and 0.015 mg ethinylestradiol per day.

Methods In the non-interventional, retrospective, multi-center study, female adults (n=100, aged between 18 and 45 years old) were analyzed. Women used the contraceptive vaginal ring Ornibel® for at least 6 months. Quality of life parameters were assessed via a patient questionnaire.

Results Most women (mean age of 28.64 ± 7.49 years; mean BMI of 23.18 ± 3.37 kg/m²) strongly agreed or agreed that Ornibel® is easy to insert (91%). They rated the use of the ring as very comfortable or comfortable (97%). The daily activities were never affected by the ring in 85% of women. Fifty percent of the partners did not notice the ring during sexual intercourse, 38% occasionally and only 6% of the partners notice the ring frequently or always. Eight women experienced a ring loss during the 6 months of the study, a number that could be expected according to the summary of product characteristics. Most women learn from their physician about the ring (81%), will continue the use of the ring (91%) and will recommend the ring (95%).

Conclusions Women feel comfortable with the contraceptive vaginal ring Ornibel®. The current observational data confirms the findings of the pharmacokinetic study that Ornibel® is a contraceptive vaginal ring that is well tolerated.

Interessenkonflikt

Pedro-Antonio Regidor ist als Medical Director Exeltis Europe Angestellter der Firma Exeltis Healthcare. Anna Müller und Manuela Sailer sind Angestellte der Firma Exeltis Healthcare. Alle anderen Autoren haben erklärt, dass kein Interessenkonflikt besteht.

Publication History

Article published online:
07 October 2020